We are thrilled to welcome Duke Rohlen as a Keynote Speaker at #LSIEurope24 in Sintra, Portugal.
Duke Rohlen is a serial entrepreneur and currently serves as CEO and Managing Director of Ajax Health, a turnkey growth solution for commercial-stage Medtech companies. Ajax Health specializes in developing comprehensive product portfolios that can be seamlessly integrated into a commercial framework.
Prior to Ajax Health, Duke co-founded and served as the Chairman and CEO of EPIX Therapeutics (acquired by Medtronic in 2019), served as co-founder and CEO of Spirox (acquired by Entellus in 2017), co-founded and served as CEO of CV Ingenuity (acquired by Covidien in 2013), served in a variety of roles at FoxHollow Technologies before being named President where he led the sale of the company to ev3 (now Medtronic) in 2008.
The Keynote will be moderated by Mano Iyer, Partner in the Sofinnova Partners MD Start Strategy and Founder of Recor Medical. Mano was also among the co-founders of the original MD Start team that incubated companies including CorWave and LimFlow.
Duke’s Keynote will be based on his recently published thesis, "The Middle Path to Innovation," published in the Harvard Business Review. He will discuss strategies for developing high-growth products in slow-growth companies and present the growth driver model—a framework that partners corporations with external investors to identify and develop innovation opportunities, drawing on corporate resources and talent and externally recruited entrepreneurs.
This Keynote will take place on September 18th (Day 2) at LSI Europe ‘24 in Sintra, Portugal.
Want to watch this Keynote live? Join nearly 1,000 global Medtech and Healthtech leaders in Sintra, Portugal this September 16-20th. Apply today while space is still available.